Tel Aviv, Israel--(Newsfile Corp. - January 22, 2024) - PainReform Ltd.(NASDAQ: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that management will be participating at The Microcap Conference which is being held on January 30 -...